About the Company:
Intuitive Surgical Inc. is an American company that is a global leader in robotic-assisted surgery. They are best known for their da Vinci Surgical System, which enables surgeons to perform minimally invasive operations with high precision.
Business Model:
Intuitive Surgical primarily generates revenue through:
Sales of surgical robotic systems (da Vinci platform)
Disposable and consumable products (instruments and accessories for procedures)
Service contracts (maintenance and support for hospitals and clinics)
Technical Analysis:
On the monthly chart, the stock is currently testing the 50-day moving average. It remains in a solid upward trend.
Looking at the weekly chart, the stock has experienced a 20% correction from the peak, which corresponds to a 61% retracement based on Fibonacci levels.
Furthermore, it has held above historical support around 470. If it breaks below this level, the next support is around 360.
RSI is currently oversold, indicating a potential buying opportunity. Historically, when RSI was near oversold levels and support was rejected, it provided good entry points.
OBV (On-Balance Volume) has shown an upward trend in recent trading days. A rising OBV following an upward price movement typically confirms strong buying interest.
Key Metrics:
P/E ratio stands at 76, slightly high compared to the industry average.
Revenue has increased by 46% since 2021, while EBITDA has grown by nearly 32%.
EPS has risen from 4.79 to an expected 6.54, indicating increased shareholder value.
Analyst Ratings:
Currently, 33 analysts cover Intuitive Surgical:
Buy: 22
Hold: 10
Sell: 1
On average, analysts believe Intuitive Surgical should be priced at DKK 626, with a target price range between 350 and 711. This implies an average upside of 27%.
Trade Strategy:
Entry price: 493
Stop-loss: 450
Take-profit: 600
Risk/reward ratio: 2.62
Intuitive Surgical Inc. is an American company that is a global leader in robotic-assisted surgery. They are best known for their da Vinci Surgical System, which enables surgeons to perform minimally invasive operations with high precision.
Business Model:
Intuitive Surgical primarily generates revenue through:
Sales of surgical robotic systems (da Vinci platform)
Disposable and consumable products (instruments and accessories for procedures)
Service contracts (maintenance and support for hospitals and clinics)
Technical Analysis:
On the monthly chart, the stock is currently testing the 50-day moving average. It remains in a solid upward trend.
Looking at the weekly chart, the stock has experienced a 20% correction from the peak, which corresponds to a 61% retracement based on Fibonacci levels.
Furthermore, it has held above historical support around 470. If it breaks below this level, the next support is around 360.
RSI is currently oversold, indicating a potential buying opportunity. Historically, when RSI was near oversold levels and support was rejected, it provided good entry points.
OBV (On-Balance Volume) has shown an upward trend in recent trading days. A rising OBV following an upward price movement typically confirms strong buying interest.
Key Metrics:
P/E ratio stands at 76, slightly high compared to the industry average.
Revenue has increased by 46% since 2021, while EBITDA has grown by nearly 32%.
EPS has risen from 4.79 to an expected 6.54, indicating increased shareholder value.
Analyst Ratings:
Currently, 33 analysts cover Intuitive Surgical:
Buy: 22
Hold: 10
Sell: 1
On average, analysts believe Intuitive Surgical should be priced at DKK 626, with a target price range between 350 and 711. This implies an average upside of 27%.
Trade Strategy:
Entry price: 493
Stop-loss: 450
Take-profit: 600
Risk/reward ratio: 2.62
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.